Evidence map›Paper›PMID 36374108›Full record

ArticlemSphere2022

Ancestral APOBEC3B Nuclear Localization Is Maintained in Humans and Apes and Altered in Most Other Old World Primate Species.

Ashley A Auerbach, Jordan T Becker, Sofia N Moraes, Seyed Arad Moghadasi, Jolene M Duda, Daniel J Salamango, Reuben S Harris

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 11 citations in OpenAlex.

  1. Collapsing retroviruses for efficient delivery of viro-toxic cargoes.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. HAMMER: Hairpin-based APOBEC3A-mediated mRNA editing reporter.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A.bioRxiv : the preprint server for biology · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ashley A Auerbach *Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, USA.ORCID 0000-0001-8505-5905
Jordan T Becker *Institute for Molecular Virology, University of Minnesotagrid.17635.36 - Twin Cities, Minneapolis, Minnesota, USA.ORCID 0000-0002-0239-5443
Sofia N MoraesInstitute for Molecular Virology, University of Minnesotagrid.17635.36 - Twin Cities, Minneapolis, Minnesota, USA.
Seyed Arad MoghadasiInstitute for Molecular Virology, University of Minnesotagrid.17635.36 - Twin Cities, Minneapolis, Minnesota, USA.
Jolene M DudaDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesotagrid.17635.36 - Twin Cities, Minneapolis, Minnesota, USA.
Daniel J SalamangoInstitute for Molecular Virology, University of Minnesotagrid.17635.36 - Twin Cities, Minneapolis, Minnesota, USA.
Reuben S HarrisDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, USA.ORCID 0000-0002-9034-9112
University of Minnesota · USHoward Hughes Medical Institute · US

Funding

PROJECT 3 – BIOLOGY OF DNA DEAMINASES IN CANCERP01CA234228 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Michael Allen Carpenter · 2019 to 2026
$14.5M
APOBEC3 Proteins in HIV RestrictionR37AI064046 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HARRIS, REUBEN S · 2015 to 2024
$4.2M
Minnesota Training Program in VirologyT32AI083196 · NIAID · UNIVERSITY OF MINNESOTA · PI Louis M Mansky · 2010 to 2026
$3.2M
APOBEC PROTEINS AND RIBOVIRAL RESTRICTIONF32AI147813 · NIAID · UNIVERSITY OF MINNESOTA · PI BECKER, JORDAN T · 2019 to 2021
$192k
A dual role for APOBEC counteraction in EBV infectionF31AI161910 · NIAID · UNIVERSITY OF MINNESOTA · PI MORAES, SOFIA · 2021 to 2021
$8k
Howard Hughes Medical InstituteNCI NIH HHS P01 CA234228NIAID NIH HHS F31 AI161910NIAID NIH HHS F32 AI147813NIAID NIH HHS R37 AI064046NIAID NIH HHS T32 AI083196
6 · The paper itself

Abstract

APOBEC3B is an innate immune effector enzyme capable of introducing mutations in viral genomes through DNA cytosine-to-uracil editing. Recent studies have shown that gamma-herpesviruses, such as Epstein-Barr virus (EBV), have evolved a potent APOBEC3B neutralization mechanism to protect lytic viral DNA replication intermediates in the nuclear compartment. APOBEC3B is additionally unique as the only human DNA deaminase family member that is constitutively nuclear. Nuclear localization has therefore been inferred to be essential for innate antiviral function. Here, we combine evolutionary, molecular, and cell biology approaches to address whether nuclear localization is a conserved feature of APOBEC3B in primates. Despite the relatively recent emergence of

Indexed as

Epstein-Barr Virus InfectionsHominidaeNeoplasmsAnimalsCytidine DeaminaseCytosineDNA ReplicationDNA, ViralHerpesvirus 4, HumanHumansMacaca mulattaMinor Histocompatibility AntigensProteinsUracilVirus ReplicationAPOBEC3A protein, humanAPOBEC3B protein, humanCytidine DeaminaseCytosineDNA, ViralMinor Histocompatibility AntigensProteinsUracilAPOBEC3BDNA cytosine deaminationhost-pathogen adaptationprimate innate immunitysubcellular localization

Identifiers

PMID36374108
PMCPMC9769932
OpenAlexW4308957808

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.